BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26016245)

  • 1. [The study of the expression and the prognostic value of Survivin and Ki67 in pancreatic endocrine tumors].
    Liu WW; Zheng Y; Xia ZL; Zhang SQ; Bao F; Lin ZM; Ji XH; Ying LL; Zhao LL; Xu MF; Cai Guo-Ping ; Chen GR
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Jan; 31(1):72-5. PubMed ID: 26016245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of survivin in pancreatic endocrine tumors.
    Ekeblad S; Lejonklou MH; Stålberg P; Skogseid B
    World J Surg; 2012 Jun; 36(6):1411-8. PubMed ID: 22089920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions and correlations of Survivin, Ki67 and p53 in laryngeal squmous cell carcinoma].
    Wang J; Yang B; Pei S; Wang X; Zhang Q; Qu F; Zhang H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 29(17):1545-8. PubMed ID: 26647541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High nuclear Survivin expression as a poor prognostic marker in pancreatic ductal adenocarcinoma.
    Zhou L; Lu J; Liang ZY; Zhou WX; Yuan D; Li BQ; You L; Guo JC; Zhao YP
    J Surg Oncol; 2018 Dec; 118(7):1115-1121. PubMed ID: 30261114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
    Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
    Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study on survivin in sinonasal tumors and its relationship with the immunoexpression of Ki67 and Bcl-2.
    Stasikowska-Kanicka O; Wagrowska-Danilewicz M; Danilewicz M
    Folia Histochem Cytobiol; 2013; 51(3):225-31. PubMed ID: 24203629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of CD99 protein expression in pancreatic endocrine tumours (PETs).
    Goto A; Niki T; Terado Y; Fukushima J; Fukayama M
    Histopathology; 2004 Oct; 45(4):384-92. PubMed ID: 15469477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of apoptotic activity, survivin, Ki-67, and P-glycoprotein expression on prognosis in pancreatic carcinoma.
    Sagol O; Yavuzsen T; Oztop I; Ulukus C; Ylmaz U; Alakavuklar M; Karademir S; Obuz F; Astarcoğlu H; Astarcoglu I
    Pancreas; 2005 May; 30(4):343-8. PubMed ID: 15841045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Subcellular localization of survivin in non-small cell lung cancer].
    He L; Hou M; Zhang J; Xu N; Chen P
    Ai Zheng; 2009 Sep; 28(9):955-60. PubMed ID: 19728914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
    He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
    Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients.
    Li S; Wang L; Meng Y; Chang Y; Xu J; Zhang Q
    Oncotarget; 2017 Jun; 8(25):41282-41293. PubMed ID: 28476037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients.
    Scarpa A; Mantovani W; Capelli P; Beghelli S; Boninsegna L; Bettini R; Panzuto F; Pederzoli P; delle Fave G; Falconi M
    Mod Pathol; 2010 Jun; 23(6):824-33. PubMed ID: 20305616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of pRb, Ki67 and HER 2/neu in gastric carcinomas: Relation to different histopathological grades and stages.
    Abdel-Aziz A; Ahmed RA; Ibrahiem AT
    Ann Diagn Pathol; 2017 Oct; 30():1-7. PubMed ID: 28965621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.
    Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Masumori N; Sato N; Tsukamoto T
    Virchows Arch; 2013 Jan; 462(1):101-7. PubMed ID: 23179762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.
    Mathieu R; Klatte T; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Bensalah K; Lotan Y; Rink M; Kluth LA; Scherr DS; Robinson BD; Shariat SF
    Urol Oncol; 2015 Nov; 33(11):495.e15-22. PubMed ID: 26228160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of ¹⁸F-FDG PET activity with expressions of survivin, Ki67, and CD34 in non-small-cell lung cancer.
    Han B; Lin S; Yu LJ; Wang RZ; Wang YY
    Nucl Med Commun; 2009 Nov; 30(11):831-7. PubMed ID: 19734817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors.
    Cherenfant J; Talamonti MS; Hall CR; Thurow TA; Gage MK; Stocker SJ; Lapin B; Wang E; Silverstein JC; Mangold K; Odeleye M; Kaul KL; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA
    Surgery; 2014 Dec; 156(6):1504-10; discussion 1510-1. PubMed ID: 25456943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin expression and serum levels in pancreatic cancer.
    Dong H; Qian D; Wang Y; Meng L; Chen D; Ji X; Feng W
    World J Surg Oncol; 2015 May; 13():189. PubMed ID: 26016480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: a comparative immunohistochemical study.
    Makboul R; Refaiy AE; Badary FA; Abdelkawi IF; Merseburger AS; Mohammed RA
    Korean J Urol; 2015 Jan; 56(1):31-40. PubMed ID: 25598934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.